Longevity
-
Epitalon Peptide Shows Mixed Results in Lab Studies on Telomeres and Cancer
While a viral reel claims Epitalon reversed aging, lab data shows it extends telomeres in healthy cells but also activates dangerous pathways…
-
Epigenetic Clocks: Measuring Biological Age and Predicting Mortality
LONDON, July 8 — The biological clock may be more than a metaphor. For over a decade, researchers have been building tools…
-
Insilico Medicine Launches Longevity Vaccines Research Initiative Targeting Aging Diseases
HONG KONG, September 15 — Insilico Medicine is taking its AI drug-discovery engine into preventive medicine. The Hong Kong-listed company (HKEX: 3696)…
-
Model Finds DNA Mutations Alone Could Cap Median Human Lifespan at 146 to 194 Years
WASHINGTON, July 14 — The global race to slow human aging is no longer a fringe scientific pursuit; it is a strategic…
-
Geneticist Nir Barzilai’s TAME Metformin Aging Trial Still Waits for Funding
NEW YORK, July 14 — The figure that matters: 200. That is the number of peer-reviewed papers Dr. Nir Barzilai has published…
-
The Hallmarks of Aging: What Drives Cellular Decline, Now 12 in Number
WASHINGTON, July 14 — A scientific framework first laid out in 2013 has become the dominant map for researchers trying to understand…
-
Aubrey de Grey: Radical Life Extension via Damage Repair
LONDON, July 10 — Aubrey de Grey, the British biomedical gerontologist whose radical vision of defeating aging has made him a polarizing…
-
Critics Question Harvard’s Sinclair Over Unproven Anti-Aging Claims and Supplement Ties
BOSTON, July 10 — The longevity research community is confronting a widening credibility gap, and Dr. David Sinclair, the Harvard Medical School…
-
Metformin and Rapamycin: Two Anti-Aging Drug Candidates With Very Different Evidence
NEW YORK, July 8 — The calculus around aging research is shifting. Two drugs, one a decades-old diabetes staple and the other…
-
Optimal strength training window linked to lower mortality rates
BOSTON, July 3 — A Harvard T.H. Chan School of Public Health study tracking 147,000 adults over 30 years has identified a…
-
Brain Changes Precede Alzheimer’s Plaques by Years, and Memory Awareness Fades Before Dementia
The clock on dementia starts ticking long before the first forgotten name. New research confirms what many in the longevity field have…
-
FDA Clears First Human Trial of Partial Epigenetic Reprogramming for Eye Disease
BOSTON, June 11 — Life Biosciences, a Boston-based longevity company, has started the first FDA-approved human clinical trial to turn back time…
-
Dr. Barzilai Targets Aging as Key to Combating Multiple Diseases
NEW YORK, July 10 — Dr. Nir Barzilai, an Israeli-American geneticist, has spent decades researching aging as a target in biomedical research.…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Bacteria Pair Cleared Tumours in Mice in 2025 Study; Not Yet Tested in People
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Sacituzumab Tirumotecan Boosts Survival in Advanced Gastroesophageal Cancer
-
FDA approves Novo Nordisk’s Sogroya as first weekly growth hormone for Turner syndrome
-
Blood Biomarker eMTBR-tau243 Detects Advanced CTE in Living Patients
-
Cemdisiran Cuts Dosing to Four Shots a Year in Myasthenia Gravis
-
AbbVie Bets $2.5 Billion on DISCO’s Bispecific Platform to Expand Oncology Pipeline
-
How to Pay Down Credit Card Debt Before Holiday Spending Peaks
-
Small Business Sale Can Trigger Up to 37% Federal Tax, New Data Shows
-
Annuity Renewal Traps: How Automatic Rollovers Lock Retirees Into Lower Rates
-
How Fed Cuts, Bank Competition and Deposit Insurance Could Crash High-Yield Savings Rates
-
How 401(k) Holders Can Automatically Cut Single-Stock Concentration Risk
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992













